1. Home
  2. ATR vs JAZZ Comparison

ATR vs JAZZ Comparison

Compare ATR & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AptarGroup Inc.

ATR

AptarGroup Inc.

HOLD

Current Price

$143.92

Market Cap

9.3B

Sector

Industrials

ML Signal

HOLD

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$189.78

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATR
JAZZ
Founded
1992
2003
Country
United States
Ireland
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
10.4B
IPO Year
1995
2007

Fundamental Metrics

Financial Performance
Metric
ATR
JAZZ
Price
$143.92
$189.78
Analyst Decision
Buy
Strong Buy
Analyst Count
4
16
Target Price
$167.50
$211.25
AVG Volume (30 Days)
591.3K
940.2K
Earning Date
05-07-2026
05-15-2026
Dividend Yield
1.35%
N/A
EPS Growth
6.51
N/A
EPS
5.89
N/A
Revenue
$3,777,181,000.00
$1,618,693,000.00
Revenue This Year
$5.29
$7.60
Revenue Next Year
$4.98
$8.34
P/E Ratio
$24.11
N/A
Revenue Growth
5.42
N/A
52 Week Low
$103.23
$95.49
52 Week High
$164.28
$198.00

Technical Indicators

Market Signals
Indicator
ATR
JAZZ
Relative Strength Index (RSI) 67.20 70.80
Support Level $135.99 $159.78
Resistance Level $163.43 N/A
Average True Range (ATR) 3.08 5.21
MACD -0.01 2.75
Stochastic Oscillator 79.91 77.33

Price Performance

Historical Comparison
ATR
JAZZ

About ATR AptarGroup Inc.

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: